Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
EPR-H5253 | Human | Human Erythropoietin R / EPO R Protein, Fc Tag | ![]() |
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Epoetin beta biosimilar (Veropharm) | Approved | Abbott | Anemia | Details | ||||||
Erythropoietin biosimilar (Fresenius Kabi Oncology) | Approved | Fresenius Kabi | Anemia | Details | ||||||
Recombinant human erythropoietin (Daying Pharma) | Approved | Daying Pharmaceutical | Anemia | Details | ||||||
Erythropoietin biosimilar (Landsteiner Scientific) | Approved | Landsteiner Scientific | Anemia | Details | ||||||
Epoetin alfa biosimilar (Wockhardt) | Approved | Wockhardt | Anemia | Details | ||||||
CKD-11101 | CKD-11101 | Approved | Chong Kun Dang | Anaemia | Details | |||||
Epoetin alfa biosimilar (Sotex Farm Firm) | Approved | Protek Group | Anemia | Details | ||||||
Epoetin alfa biosimilar (Sedico) | Approved | Sedico | Chemotherapy-induced anaemia, Anemia | Details | ||||||
Methoxy polyethylene glycol-epoetin beta | RO-0503821 ; Ro-50-3821; CERA; R-1744; R-744; RG-744,Ro503821 | Approved | Roche, Chugai, Galenica | Methoxy polyethylene glycol-epoetin beta | ema | Roche Registration GmbH | 2007-07-20 | Anemia | Details | |
Erythropoietin biosimilar (Unilab/Biomedis) | Approved | Unilab, Biomedis | Anemia | Details | ||||||
Epoetin alfa | KRN-5702,KRN5702 | Approved | Amgen, Janssen, Kyowa Hakko Kirin | EPOGEN/PROCRIT | fda | Allogeneic RBC transfusion, Anemia | AMGEN | 1989-06-01 | Allogeneic RBC transfusion, Anemia | Details |
Epoetin beta | BM-06.019; BM-06019; RO-205-3859 | Approved | Roche, Chugai, Eddingpharm | Recormon | hma | Anemia | Boehringer Mannheim GmbH Sandhofer Str. 116 D-68305 Mannheim |
1996-03-05 | Anemia | Details |
Erythropoietin biosimilar (RPG Life Sciences) | Approved | RPG Life Sciences | Anemia | Details | ||||||
Recombinant erythropoietin biosimilar (Lupin) | Approved | Lupin | Anemia | Details | ||||||
Recombinant erythropoietin (Cadila Pharmaceuticals) | Approved | Cadila | Anemia | Details | ||||||
Recombinant human erythropoietin biosimilar (North China Pharmaceutical Corporation) | Approved | North China Pharmaceutical Corporation | Recombinant Human Erythropoietin Injection(CHO Cell) | cfda | Anemia | 2015-09-01 | Anemia | Details | ||
Recombinant erythropoietin biosimilar (Elea) | Approved | Elea | Anemia | Details | ||||||
Epoetin alfa biosimilar (Claris Lifesciences) | Approved | Claris Lifesciences | Anemia | Details | ||||||
Erythropoietin (Dong-A ST) | DA-3285 | Approved | Dong-A Pharmaceutical, Dem Ilac | Anemia | Details | |||||
Recombinant Human Erythropoietin Injection (Shenzhen Saibaoer) | Approved | Shenzhen Saibaoer Biological Pharmaceutical | Recombinant Human Erythropoietin Injection(CHO cell) | cfda | Anaemia | 2015-03-12 | Anaemia | Details | ||
Erythropoietin biosimilar (Shantha Biotechnics) | Approved | Shantha Biotechnics | Anemia | Details | ||||||
Epoetin alfa biosimilar (Sun Pharmaceutical Industires) | Approved | Ranbaxy Laboratories, Sun Pharmaceutical | Anemia | Details | ||||||
Erythropoietin biosimilar (Neiss Labs) | Approved | Neiss Labs | Anemia | Details | ||||||
Erythropoietin biosimilar (Sudershan Biotech) | Approved | Sudershan Biotech Ltd | Anemia | Details | ||||||
Erythropoietin biosimilar (Incepta Pharmaceuticals) | Approved | Incepta Pharmaceuticals | Anemia | Details | ||||||
Epoetin alfa biosimilar (PT Kalbe) | Approved | Kalbe Farma | Chronic Renal Anemia, Chemotherapy-induced anaemia | Details | ||||||
Erythropoietin biosimilar (Klarvoyant Biogenics) | Approved | Klarvoyant | Anemia | Details | ||||||
Epoetin alfa biosimilar (CJ Corp) | Approved | CJ, RG Pharmaceutica, Macropharma | Anemia | Details | ||||||
Recombinant human erythropoietin alfa (Daewoong Pharmaceutical) | DWP-413,DWP 413,DWP413 | Approved | Daewoong | Anemia | Details | |||||
Recombinant erythropoietin long-acting (Shandong Kexing Bioproducts) | Approved | Shandong Kexing Bioproducts Co., Ltd | Recombinant Human Erythropoietin Injection(CHO Cell) | cfda | Anemia | 2015-02-04 | Anemia | Details | ||
Epoetin omega | HP-EPO-CRF | Approved | Elanex Pharma Group | Anemia | Details | |||||
Erythropoietin biosimilar (Micro Labs) | Approved | Micro Labs | Anemia | Details | ||||||
Darbepoetin alfa biosimilar (Dr Reddy's) | Approved | Dr Reddys Laboratories | Anemia | Details | ||||||
Recombinant human erythropoietin (Center of Molecular Immunology) | Approved | Center of molecular immunology | Aplastic anaemia | Details | ||||||
Epoetin alfa biosimilar (Biosidus) | Approved | Biosidus | Anemia | Details | ||||||
Erythropoietin biosimilar (VHB Life Sciences) | Approved | VHB Life Sciences | Anemia | Details | ||||||
Erythropoietin biosimilar (Center for Genetic Engineering and Biotechnology) | Approved | Center for Genetic Engineering and Biotechnology | Anemia | Details | ||||||
Darbepoetin alfa biosimilar (Torrent) | Approved | Torrent Pharmaceuticals | Anemia | Details | ||||||
Recombinant human erythropoietin (Shenzhen Xinpeng Bio-tech) | Approved | Shenzhen Xinpeng Biological Engineering | Recombinant Human Erythropoietin Injection(CHO Cell) | cfda | Anemia | 2015-09-08 | Anemia | Details | ||
Epoetin alfa biosimilar (Dragon Pharmaceutical) | BR-05001 | Approved | Dragon | Anemia | Details | |||||
Epoetin alfa biosimilar (Emcure) | Approved | Emcure | Anemia | Details | ||||||
Epoetin beta biosimilar (Microgen) | Approved | Microgen State Scientific Industrial | Anemia | Details | ||||||
Epoetin zeta | SB-309 | Approved | BIOCEUTICALS Arzneimittel, Hospira, STADA Arzneimittel | epoetin zeta | ema | Stada Arzneimittel AG | 2007-12-18 | Anemia | Details | |
Recombinant human erythropoietin (CHO Cell), Harbin Pharmaceutical Group Bioengineering | Approved | Harbin Pharmaceutical Group | Anemia | Details | ||||||
Epoetin alfa biosimilar (Laboratorios AC Farma) | Approved | Laboratorios AC Farma | Anemia | Details | ||||||
Erythropoietin biosimilar (Chalver Laboratorios) | Approved | Chalver Laboratorios | Anemia | Details | ||||||
Recombinant human erythropoietin (3SBio/Biolotus) | Approved | 3SBio, Biolotus | Recombinant Human Erythropoietin Injection(CHO cell) | cfda | Chemotherapy-induced anaemia | 2015-08-15 | Chemotherapy-induced anaemia | Details | ||
Epoetin alfa biosimilar (Probiomed) | Approved | Probiomed | Anemia | Details | ||||||
Recombinant human erythropoietin (Beijing Four Rings Bio-Pharmaceutical) | Approved | Beijing Four Rings Biopharmaceutical | Anemia | Details | ||||||
Darbepoetin alfa biosimilar (Hetero Drugs) | Approved | Hetero Drugs | Anemia | Details | ||||||
Darbepoetin alfa biosimilar (Kyowa Hakko Kirin) | Approved | Kyowa Hakko Kirin | Darbepoetin alfa biosimilar (Kyowa Hakko Kirin) | 日本 | Anaemia | 协和发酵麒麟 | 2018-08-15 00:00:00.0 | Anaemia, Anemia | Details | |
Epoetin beta biosimilar (CinnaGen) | Approved | CinnaGen | Anemia | Details | ||||||
Epoetin theta | Approved | Teva | epoetin theta | ema | Teva GmbH | 2009-10-23 | Anemia | Details | ||
Epoetin alfa biosimilar (Biocon) | Approved | Biocon BioPharmaceuticals | Anemia | Details | ||||||
Epoetin alfa biosimilar (LG Life Sciences) | Approved | LG Life Sciences | Anemia | Details | ||||||
Epoetin alfa biosimilar (Siam Bioscience) | Approved | Siam Bioscience | Anemia | Details | ||||||
Recombinant erythropoietin biosimilar (Recpharma) | Approved | ReceptoPharm | Anemia | Details | ||||||
Epoetin alfa biosimilar (Laboratorios Bioprofarma) | Approved | Laboratorios Bioprofarma | Anemia | Details | ||||||
Epoetin alfa biosimilar (Sandoz) | HX-575 | Approved | Sandoz, Medice Arzneimittel, Hexal | epoetin alfa | ema | Hexal AG | 2007-08-27 | Anemia | Details | |
Epoetin alfa biosimilar (Laboratorio Varifarma) | Approved | Laboratorio Varifarma | Anemia | Details | ||||||
Recombinant human erythropoietin (Chengdu Diao Group) | Approved | Chengdu Diao Group | Recombinant Human Erythropoietin for Injection(CHO Cell) | cfda | Anemia | 2015-08-31 | Anemia | Details | ||
Darbepoetin alfa (Amgen) | Epo-N47; KRN-321; N-47 | Approved | Amgen, Kyowa Hakko Kirin, Dompe Farmaceutici | darbepoetin alfa | ema | Amgen Europe B.V. | 2001-06-08 | Anemia | Details | |
Epoetin beta biosimilar (Pharmapark) | Approved | Pharmapark | Anemia | Details | ||||||
Erythropoietin biosimilar (Zuventus Healthcare) | Approved | Zuventus Healthcare | Anemia | Details | ||||||
Epoetin alfa biosimilar (Intas BioPharmaceuticals) | Approved | Intas Biopharmaceuticals | Anemia | Details | ||||||
Epoetin biosimilar (Zydus Cadila) | Approved | Zydus cadila | Anemia | Details | ||||||
Darbepoetin alfa biosimilar (JCR Pharmaceuticals/Kissei Pharmaceutical) | JR-131 | Approved | Kissei, JCR Pharmaceuticals | Anemia | Details | |||||
Epoetin alfa biosimilar (Amega Bitoech) | Approved | Amega Biotech | Anemia | Details | ||||||
Epoetin alfa biosimilar (Nanogen) | Approved | Nanogen Biopharmaceutical Co | Anemia | Details | ||||||
Human erythropoietin biosimilar (Celon Laboratories) | Approved | Celon Laboratories | Anemia | Details | ||||||
Epoetin alfa biosimilar (Reliance Life Sciences) | Approved | GeneMedix Plc, Reliance Life Sciences, Stragen Pharma | Anemia | Details | ||||||
Recombinant erythropoietin (Shanghai Chemo Wanbang Biopharma) | Approved | Shanghai ChemoWanbang Biopharma | Anemia | Details | ||||||
Epoetin kappa (JCR Pharmaceuticals) | JR-013,JR013 | Approved | JCR Pharmaceuticals, Kissei | Epoetin kappa (JCR Pharmaceuticals) | 日本 | Anemia | JCR Pharmaceuticals | 2010-01-20 00:00:00.0 | Anemia | Details |
Erythropoietin biosimilar (Genius Biotherapeutics) | Approved | Genius Biotherapeutics | Anemia | Details | ||||||
Recombinant human erythropoietin (Shandong Ahua Biochemical) | Approved | Shandong Ahua Biochemical | Anemia | Details | ||||||
Darbepoetin alfa biosimilar (Dong-A ST) | DA-3880; GBS-011 | Approved | Dong-A Pharmaceutical, Sanwa Kagaku Kenkyusho | Anemia | Details | |||||
Epoetin alfa biosimilar (Blau Farmaceutica) | Approved | Blau Farmaceutica | Anemia | Details | ||||||
Epoetin alfa (Pooyesh Darou Pharmaceuticals) | Approved | Pooyesh Darou | Anemia | Details | ||||||
Epoetin alfa biosimilar (Fiocruz/Bio-Manguinhos) | Approved | Fundacao Oswaldo Cruz (FIOCRUZ) | Anemia | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Epoetin alfa biosimilar (Apotex) | APO-EPO | Phase Ⅲ | Apotex | Anemia | Details |
Recombinant human erythropoietin (Max Planck Institute) | Phase Ⅱ | Max Planck Institute of Experimental Medicine | Schizophrenia, Multiple sclerosis (MS) | Details | |
Erythropoietin (Epoplus) | Phase Ⅰ | Cytonet | wound, Renal failure | Details | |
Recombinant human erythropoietin-Fc fusion protein (Dongguan baolijian Biotech) | Phase Ⅰ | Dongguan baolijian biotech, Dongguan Tai Li Bioengineering Co. | Anemia | Details | |
Recombinant erythropoietin (Prolong Pharmaceuticals/Zydus Cadila) | ZY-7318 | Phase Ⅰ | Prolong Pharmaceuticals, Zydus cadila | Anemia | Details |
Recombinant human erythropoietin (Hanyang University Seoul Hospital) | Phase Ⅱ | Hanyang University | Amyotrophic lateral sclerosis (ALS) | Details | |
Epoetin alfa biosimilar (UBI Pharma) | UB-851 | Phase Ⅲ | United Biomedical | Anaemia | Details |
Erythropoietin (Y-shaped pegylation, Xiamen Amoytop Biotech) | Phase Ⅰ | Xiamen Amoytop Biotech, BioGeneric | Somatotropin deficiency, Idiopathic short stature, Anemia | Details | |
Long-acting erythropoietin (Teva) | Preclinical | CSL Behring, Teva | Anemia | Details | |
R-1516 | R-1516 | Phase Ⅰ | Gryphon Therapeutics, Roche | Anemia | Details |
Peginesatide acetate | AF-37702; Peptidic ERA | Withdrawn | Affymax, Takeda | Anemia | Details |
LU AA 24493 | Lu-AA24493 | Phase Ⅱ | Warren Pharmaceuticals, Lundbeck | Friedreich's ataxia, Stroke | Details |
CNTO528 | CNTO-528; CNTO 528; CNTO528 | Phase Ⅰ | Centocor, Janssen, Johnson & Johnson | Anemia | Details |
rhEPO-Fc (Shanghai Meiye Biotechnology) | Phase Ⅰ | Shanghai meiye Biotech | Anemia | Details | |
Pegylated recombinant human erythropoietin (Shenzen Saibaoer Biotech) | Phase Ⅱ | Shenzhen Saibaoer Biological Pharmaceutical | Chronic Renal Anemia | Details | |
Erythropoietin (Neose) | NE-180 | Phase Ⅱ | Neose Technologies | Anemia | Details |
Darbepoetin alfa biosimilar (Biocad) | BCD-066 | Phase Ⅲ | Biocad | Anemia | Details |
Erythropoietin biosimilar (AXXO) | Phase Not Specified | AXXO | Chemotherapy-induced anaemia | Details | |
Darbepoetin alfa biosimilar (AvesthaGen) | Phase Ⅲ | Avesthagen, QuintilesIMS | Anemia | Details | |
Recombinant human erythropoietin-Fc fusion protein (Shanhai meiye Biotech) | Phase Ⅱ | Shanghai meiye Biotech | Anemia | Details | |
Recombinant human erythropoietin (Uni-Bio Science Group) | Phase Ⅰ | Uni-Bio Science Group | Anemia | Details | |
Albumin-erythropoietin fusion protein (Tianjin SinoBiotech) | Phase Ⅰ | Tianjin SinoBiotech | Anemia | Details | |
Efepoetin alfa | EPO-hFC; EPO-hybrid-Fc; EPO-hyFc; GC-1113; GX-E2 | Phase Ⅲ | Genexine, Green Cross, Shanghai ChemoWanbang Biopharma | Anemia | Details |
PEGylated erythropoietin (Intas Biopharmaceuticals) | Phase Ⅲ | Intas Biopharmaceuticals | Anemia | Details | |
NTx-488 | NTx-488 | Preclinical | Trillium Therapeutics Inc | Multiple sclerosis (MS) | Details |
Recombinant human erythropoietin-CTP fusion protein (Harbin Pharmaceutical) | Phase Ⅰ | Harbin Pharmaceutical Group | Anemia | Details | |
Pegylated darbepoetin beta | BCD-131 | Phase Ⅱ | Biocad | Anemia | Details |
Recombinant human erythropoietin (Snow Brand Milk Products) | Phase Ⅲ | Snow Brand Milk Products | Haematological disorders | Details | |
Epoetin delta (Shire) | MDL-104396; HMR-4396 | Withdrawn | Shire, Sanofi | Renal failure, Anemia | Details |
Recombinant erythropoietin (Syntonix) | Phase Ⅰ | Biogen Idec | Anemia | Details | |
Epoetin alfa biosimilar (PanGen Biotech) | PDA-10 | Phase Ⅲ | PanGen Biotech | Anemia | Details |
Darbepoetin alfa biosimilar (CJ Healthcare) | CJ-40001; YLB-217 | Phase Ⅱ | CJ CheilJedang, North China Pharmaceutical Corporation | Anemia | Details |
Recombinant human erythropoietin (Shanghai Huaxin) | IND Filing | Shanghai Hua Xin High Biotechnology Inc | Anaemia | Details | |
Pegylated darbepoetin alfa biosimilar (Merck & Co.) | MK-2578 | Phase Ⅱ | Merck Sharp & Dohme | Anemia | Details |
MDGN-201 | MDGN-201 | Phase Ⅱ | Aevi Genomic Medicine | Anemia | Details |
LKA-651 | LKA-651; LKA651 | Phase Ⅱ | Alcon, MorphoSys | Diabetic macular edema | Details |
Darbepoetin alfa biosimilar (Nichi-Iko Pharmaceutical/Aprogen) | AP-032 | Preclinical | Aprogen, Nichi-Iko Pharmaceutical | Anemia | Details |
Darbepoetin alfa biosimilar (PanPharmaceuticals) | Phase Not Specified | PanPharmaceuticals | Anemia | Details | |
Recombinant erythropoietin stimulating protein (3SBio) | Phase Ⅱ | 3SBio | Chronic Renal Failure | Details | |
Pegol-Sihematide | EPO-018B | Phase Ⅲ | Hansoh Pharma | Anemia, Chronic kidney disease | Details |
Recombinant erythropoietin (Bio-Ker) | Phase Not Specified | Bio-Ker | Unspecified | Details | |
Erythropoietin long-acting (Hanmi) | HM-10760A; LAPS-EPO,HM 10760A; LAPS EPO,HM10760A | Phase Ⅰ | Hanmi | Anemia | Details |
Recombinant erythropoietin (XTL) | EPO-XTL; rHuEPO-XTL | Phase Ⅰ | Bio-GAL, XTL Biopharmaceuticals | Multiple myeloma (MM) | Details |
Erythropoietin polysialic (Xenetic Biosciences) | PSA-EPO; SYN-20070131RU | Phase Ⅲ | Lipoxen Technologies, Serum Institute of India, Xenetic Biosciences, SynBio | Anemia | Details |
Novel erythropoiesis stimulant (Centergene) | Phase Ⅰ | Centergene Pharmaceuticals, Suzhou Kangju Biotechnology Co., Ltd., Shanghai Qiangbang Biotechnology Co., Ltd. | Anemia | Details | |
Erythropoietin biosimilar (Pooyesh Darou) | Phase Ⅱ | Pooyesh Darou | Anemia | Details | |
Erythropoietin receptor agonist (Biocad) | Phase Ⅰ | Biocad, Ligand | Haematological disorders | Details | |
Recombinant erythropoietin fusion protein (Merck Serono) | Phase Ⅰ | Merck Serono | Anemia | Details | |
Erythropoietin biobetter (Nautilus/HanAll) | HL-033 | Phase Ⅰ | Nautilus Biotech, HanAll | Anemia | Details |
Epoetin alfa biosimilar (Biocad) | Phase Ⅰ | Biocad | Anemia | Details | |
Darbepoetin alfa biosimilar (Reliance Life Sciences) | RTPR-026; R-TPR-026 | Phase Ⅲ | Reliance Life Sciences | Anemia | Details |
Darbepoetin alfa biosimilar (3SBio) | SSS-06 | Phase Ⅱ | 3SBio | Anemia | Details |
Epoetin beta biosimilar (Biocad) | Phase Ⅰ | Biocad | Anemia | Details |
This web search service is supported by Google Inc.